Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sutro Biopharma
Biotech
Ipsen joins ADC race via $900M biobuck deal with Sutro
Ipsen is the newest entrant in the antibody-drug conjugate race, handing over around $90 million in near-term payments to Sutro Biopharma
James Waldron
Apr 2, 2024 7:26am
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am
Blackstone, Sutro ink royalty pact worth up to $390M biobucks
Jun 26, 2023 1:47pm
Frazier departs Merck after 30 years—Chutes & Ladders
Oct 28, 2022 9:30am
Astellas pays Sutro $90M to hit tumor with ADC twist’s 1-2 punch
Jun 28, 2022 5:48am
BioNova adds to blood cancer portfolio with $200M Sutro deal
Oct 12, 2021 10:49am
